C. Mendrick

发表

Interaction between Posaconazole and Caspofungin in Concomitant Treatment of Mice with Systemic Aspergillus Infection

D. Loebenberg, A. Cacciapuoti, J. Halpern, 2006, Antimicrobial Agents and Chemotherapy.

Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to Azoles

D. Loebenberg, C. Mendrick, A. Chau, 2004, Antimicrobial Agents and Chemotherapy.

In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts

D. Loebenberg, P. Mann, C. Mendrick, 2006, Antimicrobial Agents and Chemotherapy.

EmtA, a rRNA methyltransferase conferring high‐level evernimicin resistance

F. Aarestrup, A. Mankin, R. Goering, 2001, Molecular microbiology.

Evernimicin (SCH27899) Inhibits a Novel Ribosome Target Site: Analysis of 23S Ribosomal DNA Mutants

D. Loebenberg, K. Klugman, K. Shaw, 2000, Antimicrobial Agents and Chemotherapy.

Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species

P. Mann, C. Mendrick, Reena Patel, 2009, Antimicrobial Agents and Chemotherapy.

In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, againstAspergillus and Candida

D. Loebenberg, F. Menzel, A. Cacciapuoti, 2000, Antimicrobial Agents and Chemotherapy.

Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.

D. Loebenberg, B. Didomenico, J. Lopez-Ribot, 2003, The Journal of antimicrobial chemotherapy.

Mutations in Aspergillus fumigatus Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14α-Demethylase

D. Loebenberg, B. Didomenico, P. Mann, 2003, Antimicrobial Agents and Chemotherapy.

Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors

R. J. Herr, P. Mann, S. Walker, 2011, Antimicrobial Agents and Chemotherapy.